(Q37368387)

20 August 2017

Randomized, controlled trial of telcagepant for the acute treatment of migraine (English)

1 reference

randomized controlled trial

20 August 2017

1 reference

1 reference

0 references

10

0 references

author name string

K M Connor

1

1 reference

20 August 2017

R E Shapiro

2

1 reference

20 August 2017

H-C Diener

3

1 reference

20 August 2017

S Lucas

4

1 reference

20 August 2017

J Kost

5

1 reference

20 August 2017

X Fan

6

1 reference

20 August 2017

K Fei

7

1 reference

20 August 2017

C Assaid

8

1 reference

20 August 2017

C Lines

9

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

20 August 2017

1 reference

20 August 2017

73

1 reference

20 August 2017

12

1 reference

20 August 2017

970-977

1 reference

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754336

Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754336

Calcitonin gene-related peptide and its role in migraine pathophysiology

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754336

Vascular actions of calcitonin gene-related peptide and adrenomedullin

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754336

Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754336

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754336

The International Classification of Headache Disorders: 2nd edition

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754336

CGRP may play a causative role in migraine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754336

Advances in pharmacological treatment of migraine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754336

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754336

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754336

No increase of calcitonin gene-related peptide in jugular blood during migraine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754336

BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754336

The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754336

Validation of a new quality of life questionnaire for acute migraine headache.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754336

Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19770473

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1212/WNL.0B013E3181B87942

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

19770473

1 reference